The Everkind Research Range: A Complete Guide to the Current Catalogue

One of the most common questions we get is deceptively simple: "What do you actually stock — and what is it all for?"

Fair question. Peptide catalogues tend to read like alphabet soup, and the shorthand doesn't help. So this is the plain-English version: a walk through the entire current Everkind research range, grouped by what researchers actually study them for.

First, a quick note on our own shorthand, because it trips people up on packing lists and invoices. On our end, CP = CJC-1295 + Ipamorelin, our dual-secretagogue blend. If you see "CP10" on a label or order, that's the CJC + Ipa blend in the 10mg presentation. Now, the full range.

Disclaimer: This article is for educational and research purposes only. It is not medical advice, and these compounds are intended for research use only.

Growth Hormone Secretagogues

These compounds are studied for how they stimulate the body's own pulsatile growth hormone release rather than supplying GH directly.

• CJC-1295 + Ipamorelin (CP) — our most popular secretagogue pairing. CJC-1295 (NO DAC) acts on GHRH receptors; Ipamorelin is a selective ghrelin-mimetic (GHS) receptor agonist. Together they're studied for synergistic GH pulse amplitude without the cortisol or prolactin spillover seen with older secretagogues. Available as the CP blend or as standalone CJC-1295 NO DAC and Ipamorelin.
• Tesamorelin — the GHRH analogue with the deepest clinical literature, including an FDA-approved indication in HIV-associated lipodystrophy. Studied for visceral adipose tissue and IGF-1 dynamics.
• Ipamorelin — on its own, the cleanest of the GHS class: GH-selective with minimal off-target hormone activity.

Metabolic & Weight-Management Research

The most-watched category in peptide science right now.

• Retatrutide — the GIP/GLP-1/glucagon triple agonist. Stocked in 10mg, 20mg and 30mg so studies can scale across the dose ranges used in published trials. Phase 3 data in 2026 has only intensified interest.
• Tirzepatide — the dual GIP/GLP-1 agonist that set the benchmark retatrutide is now being compared against.
• Semaglutide — the reference GLP-1 agonist; still the baseline comparator in most metabolic research design.
• Cagrilintide — the amylin analogue being studied alongside GLP-1 agonists for complementary appetite and gastric-emptying pathways.
• AOD-9604 — the C-terminal fragment of hGH studied for lipolysis without full GH activity.
• 5-Amino-1MQ — an NNMT inhibitor studied for cellular energy metabolism and NAD+ salvage pathways.
• MOTS-c — a mitochondrial-derived peptide studied for metabolic homeostasis and exercise-mimetic signalling. Available in 10mg and 40mg.

Repair, Recovery & Tissue Research

• BPC-157 — the gastric-derived pentadecapeptide at the centre of an enormous preclinical literature on tendon, gut and soft-tissue repair models.
• TB-500 — the thymosin beta-4 fragment studied for actin regulation, cell migration and angiogenesis.
• BPC-157 + TB-500 — the classic recovery pairing in a single blend, available in 10mg and 20mg total presentations.
• ARA 290 — the erythropoietin-derived peptide studied for innate repair receptor activation and neuropathic models.
• KPV — the alpha-MSH tripeptide fragment studied for inflammatory signalling, particularly in gut and skin models.

Skin, Collagen & Copper Peptides

• GHK-Cu — the copper tripeptide with decades of literature on collagen synthesis, wound models and skin biology. Instantly recognisable by its royal blue powder.
• GLOW — our skin-focused blend built around GHK-Cu.
• KLOW — the multi-component blend pairing GHK-Cu with repair and signalling peptides for broader dermal and systemic research models.

Cognitive & Neurological Research

• Semax — the ACTH(4-7) analogue studied for BDNF expression, attention and neuroprotection models.
• Selank — the tuftsin analogue studied for anxiolytic signalling and GABAergic modulation.
• DSIP — the delta sleep-inducing peptide, a long-running subject of sleep-architecture research.

Longevity & Cellular Health

• NAD+ — the central redox coenzyme. Declining NAD+ availability is one of the most replicated findings in aging biology, and replenishment strategies are an active research area.
• SS-31 — the mitochondria-targeted peptide studied for cardiolipin stabilisation and mitochondrial membrane function.
• Epithalon-class and telomere-adjacent research continues to grow; watch this space.

Pigmentation Research

• Melanotan I — the linear alpha-MSH analogue studied for melanogenesis.
• Melanotan II — the cyclic analogue with broader melanocortin receptor activity.

The Essentials

• BAC Water — bacteriostatic water for reconstitution. Not glamorous, but no protocol runs without it, which is exactly why we stock it.

How Researchers Usually Combine Them

Most research designs don't use compounds in isolation. The pairings we see most often:

• GH axis studies: CJC-1295 + Ipamorelin (the CP blend) — GHRH and GHS pathways stimulated together, mirroring how GH is naturally pulsed.
• Recovery stacks: BPC-157 + TB-500, sometimes with KPV for the inflammatory arm.
• Metabolic designs: a GLP-1-class agonist as the primary variable, with MOTS-c or 5-Amino-1MQ in mitochondrial-secondary designs.
• Skin and collagen models: GHK-Cu-based blends (GLOW, KLOW) alongside repair peptides.

Final Thoughts

A catalogue is easier to navigate once you stop reading it as a list of names and start reading it as a map of research questions. GH secretion, metabolism, tissue repair, skin biology, cognition, longevity — that's the shape of the current Everkind range, and CP (CJC-1295 + Ipamorelin) sits right at the centre of the GH corner of that map.

Every compound ships from our Australian facility with COAs available on the site, and the range keeps growing as the research does.

Disclaimer: This article is educational only. All compounds discussed are supplied strictly for laboratory research use and are not approved for human or veterinary use.